Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

NCT ID: NCT04642001

Last Updated: 2020-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-07

Study Completion Date

2020-11-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized, double-blind clinical trial evaluated the effect of photobimodulation associated with 8% strontium acetate in the treatment of dentin hypersensitivity in non-carious lesions and analyzed the risk factors with the patient's quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group G1

Photon Laser III-DMC (without radiation emission) + My First- Colgate

Group Type OTHER

Photon Laser III-DMC (without radiation emission) + My First- Colgate

Intervention Type OTHER

Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Group G2

Photon Laser III-DMC (without radiation emission) + Sensodyne® Rápido Alívio/GSK

Group Type EXPERIMENTAL

Photon Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK

Intervention Type OTHER

Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Group G3

Photon Laser III-DMC (with irradiation emission) + My First- Colgate

Group Type EXPERIMENTAL

Photon Laser III-DMC (with irradiation emission) + My First- Colgate

Intervention Type RADIATION

Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Group G4

Photon Laser III-DMC (with irradiation emission) + Sensodyne® Rápido Alívio/GSK

Group Type EXPERIMENTAL

Photon Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK

Intervention Type COMBINATION_PRODUCT

Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Photon Laser III-DMC (without radiation emission) + My First- Colgate

Positioning of the FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Intervention Type OTHER

Photon Laser III-DMC (without radiation emission) + Sensodyne® Rapid Relief / GSK

Positioning of FBM (Photon Laser III / DMC) without emitting radiation, the equipment's sound was mimicked with the Beep application (Foncannon Inc, Google, © 2018), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Intervention Type OTHER

Photon Laser III-DMC (with irradiation emission) + My First- Colgate

Emission of FBM therapy (Photon Laser III / DMC), followed by the use of fluoride-free toothpaste (My First- Colgate) and brushing three times a day.

Intervention Type RADIATION

Photon Laser III-DMC (with irradiation emission) +Sensodyne® Rapid Relief / GSK

Emission of FBM therapy (Photon Laser III / DMC), followed by the application of toothpaste containing strontium acetate (Sensodyne® Rapid Relief / GSK) and brushing three times a day.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 to 50 years
* Good general health
* Dental sensitivity with response ≥ 4 on the 10 cm long visual analog scale (EVA)
* Presence of at least two hypersensitive teeth with a depth of up to 1 mm (measured with a millimeter probe)
* Exposed root surface caused by abrasion, erosion or gum recession

Exclusion Criteria

* Volunteers using analgesic medication
* Presence of teeth with evidence of carious lesions, pulpitis, defective restorations and moderate or severe periodontal disease
* Patients who had undergone any whitening therapy or professional or homemade desensitizer in the last six months
* Patient with fixed orthodontic appliances
* Drug users or pregnant women were also excluded.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal do Para

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cecy Martins Silva

clinical professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidade Federal do Pará

Belém, Pará, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UFPara-009

Identifier Type: -

Identifier Source: org_study_id